| Symbol |
Name |
|
ACVR2B
|
activin A receptor, type IIB
|
|
ADAM19
|
ADAM metallopeptidase domain 19
|
|
ADRB3
|
adrenoceptor beta 3
|
|
ALOX12
|
arachidonate 12-lipoxygenase
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
APOE
|
apolipoprotein E
|
|
AR
|
androgen receptor
|
|
ARHGAP1
|
Rho GTPase activating protein 1
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
C17ORF53
|
chromosome 17 open reading frame 53
|
|
C7ORF76
|
chromosome 7 open reading frame 76
|
|
CCDC170
|
coiled-coil domain containing 170
|
|
CER1
|
cerberus 1, DAN family BMP antagonist
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CLCN7
|
chloride channel, voltage-sensitive 7
|
|
CLEC10A
|
C-type lectin domain family 10, member A
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COMT
|
catechol-O-methyltransferase
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2R1
|
cytochrome P450, family 2, subfamily R, polypeptide 1
|
|
DBP
|
D site of albumin promoter (albumin D-box) binding protein
|
|
DHCR7
|
7-dehydrocholesterol reductase
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
F2
|
coagulation factor II (thrombin)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
FABP3
|
fatty acid binding protein 3, muscle and heart
|
|
FAM210A
|
family with sequence similarity 210, member A
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FMN2
|
formin 2
|
|
FOXL1
|
forkhead box L1
|
|
FTO
|
fat mass and obesity associated
|
|
GALNT3
|
polypeptide N-acetylgalactosaminyltransferase 3
|
|
GC
|
group-specific component (vitamin D binding protein)
|
|
GDF5
|
growth differentiation factor 5
|
|
GIPR
|
gastric inhibitory polypeptide receptor
|
|
GPATCH1
|
G patch domain containing 1
|
|
GREM2
|
gremlin 2, DAN family BMP antagonist
|
|
HDAC5
|
histone deacetylase 5
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
IBSP
|
integrin-binding sialoprotein
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IL15
|
interleukin 15
|
|
IL6
|
interleukin 6
|
|
INSIG2
|
insulin induced gene 2
|
|
ITGA1
|
integrin, alpha 1
|
|
JAG1
|
jagged 1
|
|
LACE1
|
lactation elevated 1
|
|
LCT
|
lactase
|
|
LDLR
|
low density lipoprotein receptor
|
|
LINC00326
|
long intergenic non-protein coding RNA 326
|
|
LRP4
|
low density lipoprotein receptor-related protein 4
|
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
LTBP3
|
latent transforming growth factor beta binding protein 3
|
|
MARK3
|
MAP/microtubule affinity-regulating kinase 3
|
|
MC4R
|
melanocortin 4 receptor
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MEF2C
|
myocyte enhancer factor 2C
|
|
MEPE
|
matrix extracellular phosphoglycoprotein
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MSTN
|
myostatin
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTR
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
|
MYOD1
|
myogenic differentiation 1
|
|
MYOG
|
myogenin (myogenic factor 4)
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NR1D1
|
nuclear receptor subfamily 1, group D, member 1
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
P2RX4
|
purinergic receptor P2X, ligand gated ion channel, 4
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2
|
|
PLCL1
|
phospholipase C-like 1
|
|
PRDM2
|
PR domain containing 2, with ZNF domain
|
|
PTH
|
parathyroid hormone
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
|
PTH2R
|
parathyroid hormone 2 receptor
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
RSPO3
|
R-spondin 3
|
|
RUNX2
|
runt-related transcription factor 2
|
|
SEMA7A
|
semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group)
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SLC25A13
|
solute carrier family 25 (aspartate/glutamate carrier), member 13
|
|
SOST
|
sclerostin
|
|
SOX4
|
SRY (sex determining region Y)-box 4
|
|
SOX6
|
SRY (sex determining region Y)-box 6
|
|
SP7
|
Sp7 transcription factor
|
|
SPTBN1
|
spectrin, beta, non-erythrocytic 1
|
|
STARD3NL
|
STARD3 N-terminal like
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
THRA
|
thyroid hormone receptor, alpha
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TMEM135
|
transmembrane protein 135
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TOB1
|
transducer of ERBB2, 1
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
WLS
|
wntless Wnt ligand secretion mediator
|
|
WNT16
|
wingless-type MMTV integration site family, member 16
|
|
ZBTB40
|
zinc finger and BTB domain containing 40
|
